drugset / Trial / NCT02950103

Efficacy and Safety of Synthetic Phosphoethanolamine in Solid Tumor Patients

NCT02950103 ↗

NaSingle-groupOpen-labelTreatment

Summary

Synthetic phosphoethanolamine is a primary amine which has a critical role in the biosynthesis of cell membranes. Pre-clinical models have shown potential anticancer activity.

Timeline

Start
2016-08
Primary completion
2017-03
Completion
2019-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Phosphoethanolamine Small molecule — Oral

Indications